Director, Oncology National Accounts
Ferring
About this role
As the Director of Oncology National Accounts at Ferring, you will play a critical role in promoting a new intravesical gene therapy by establishing and maintaining relationships with premier national oncology accounts. This position focuses on achieving strategic business objectives through collaboration with internal and external stakeholders to ensure the successful pull-through of therapy at the local level.
Skills
Qualifications
About Ferring
ferringusa.comN/A
Recent company news
Business WireFerring Highlights New Real-World Research with ADSTILADRIN
Oct 28, 2025
BioSpaceFerring Unveils New Data with ADSTILADRIN® (nadofaragene firadenovec-vncg) at 112th Annual Meeting of the Japanese Urological Association
Apr 21, 2025
Fierce PharmaFerring opens doors to Finnish manufacturing hub as supply of its bladder cancer gene therapy continues to grow
Oct 3, 2024
Yahoo FinanceU.S. FDA Approves Second Drug Product Manufacturing Facility for ADSTILADRIN® (nadofaragene firadenovec-vncg)
Apr 24, 2025
Endpoints NewsADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence
Apr 21, 2025
About Ferring
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Ferring.
Salary
$226k – $240k
per year